Related Experiment Video
Updated: Jun 3, 2025

Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
Screening for Financial Toxicity in Oncology Research and Practice: A Narrative Review
Jeffrey Peppercorn1, Matthew Gelin1, Taylor E Masteralexis1
1Department of Medicine, Massachusetts General Hospital, Boston, MA.
Financial toxicity (FT), a significant burden for cancer patients, is increasingly addressed through validated research tools. Efforts are underway to develop brief screening methods for clinical practice to aid those facing financial distress.
Area of Science:
- Oncology
- Health Economics
- Patient Support
Background:
- Financial toxicity (FT) is a recognized problem impacting cancer patients and their families.
- The field is shifting from problem description to developing screening and management solutions.
- Multiple validated tools exist for FT research, with ongoing development for clinical screening.
Purpose of the Study:
- To review validated scales for studying FT in research settings.
- To present examples of tools being evaluated for clinical screening of FT.
- To highlight the importance of identifying and assisting patients experiencing FT.
Main Methods:
- Narrative review of existing literature on FT assessment tools.
- Analysis of validated scales used in research.
- Examination of tools being studied for clinical implementation.
Main Results:
- Numerous validated tools are available for FT research.
- Emerging evidence supports brief screening (1-2 questions) for financial distress.
- Various tools are being tested for routine clinical practice integration.
Conclusions:
- Clinicians should actively identify and support patients experiencing FT.
- Validated research tools provide a foundation for clinical screening development.
- Effective screening and management of FT are crucial for comprehensive cancer care.
More Related Videos
Related Concept Videos
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Treatment Resistant Cancers

